Stocks and Finance

Pfizer

Pfizer 2/6/2012

19:23 : Pfizer Birth Control Recall: Could Women Sue? - It was a rare case where a megalith drug company's error could lead to a truly jarring side effect: pregnancy. Which begs the question: Could Pfizer realistically pay damages as the result of an unexpected pregnancy caused by a recall' Could ...
Source : ibtimes-com

Pfizer 2/2/2012

09:30 : Pfizer Birth Control Recall Raises Risk of Unplanned Pregnancy - Pfizer Inc is reaching out directly to women consumers to warn them about its U.S. recall of one million packets of birth control pills as concerns mounted that a manufacturing error could raise the risk of unplanned pregnancies.
Source : ibtimes-com

Pfizer 2/1/2012

17:31 : Investors Ignore Pfizer Birth Control Recall, Shares End Higher - Pfizer, the world's biggest drug company, appeared Wednesday to have escaped negative investor reaction after announcing a recall of birth-control pills, with stock prices fluctuating throughout the trading session before closing up 13 cents ...
Source : ibtimes-com
13:06 : Pfizer Recalls 1M Birth Control Packs - The company announced a recall of birth control pills due to a packaging error that could leave women with an inadequate dose of the hormone-based drugs and increase the chances of getting pregnant accidentally.
Source : foxbusiness-com
11:57 : Pfizer Recalls 28 Lots of Birth-Control Pills - Pfizer is recalling two types of birth-control pills because the packages might not contain the right mix of pills, raising the risk of an unplanned pregnancy.
Source : wsj-com
11:34 : Pfizer, Akrimax recall birth control pills that may not work - Pfizer Inc. said it is voluntarily recalling 28 lots of its birth control products Lo/Ovral, Norgestrel and Ethinyl Estradiol. Because of a packaging error, Pfizer officials said, the daily regimen for these oral contraceptives ...
Source : bizjournals-com

Pfizer 1/31/2012

12:13 : Pfizer Profits Halved As Lipitor Comes Off Patent - Pfizer booked a sharp decline in fourth-quarter profit Tuesday, and more importantly cut its 2012 outlook as it projects its first year of results after patent expiration on cholesterol drug Lipitor.
Source : forbes-com
11:05 : Generics take toll on Pfizer, Lilly profits - (Reuters) - Competition from low-cost generic drugs squeezed quarterly profits at Pfizer Inc and Eli Lilly & Co but the drugmakers were able to somewhat weather those declines with help from other medicines.
Source : reuters-com
10:11 : Pfizer 4Q Revenues Down, Profits Still Up - Pfizer remained profitable despite a reported drop in quarterly earnings, beating analysts' dire predictions of lost revenue to generic versions of its best-selling drug Lipitor through its non-pharmaceutical units and cost cutting.
Source : ibtimes-com
09:18 : Futures Rise on EU Budget Pact; Pfizer and Exxon Mobil Earnings in Focus - The Dow Jones industrial Average (DJIA) headed for a positive open this morning, as Wall Street cheers a euro-zone pact for tougher budget rules and progress on Greece's debt issues. Heading into the open, ...
Source : forbes-com
08:48 : Pfizer trims 2012 view, citing stronger dollar - (Reuters) - Pfizer Inc reported sharply lower quarterly earnings, hurt by generic forms of its Lipitor cholesterol drug, and the company trimmed its 2012 forecasts due to negative effects of the stronger dollar.
Source : reuters-com
08:18 : Pfizer, Lilly Profit Slumps - Pfizer's profit fell 50% on one-time charges and a drop in U.S. revenue, which was hurt by cholesterol drug Lipitor losing patent protection. Eli Lilly's net income tumbled 27% on the loss of a patent protecting its top-seller Zyprexa.
Source : wsj-com
08:01 : Pfizer 4Q net falls by half after generic Lipitor - NEW YORK (AP) -- Pfizer Inc. said Tuesday that its fourth-quarter profit fell by half due to one-time charges and a drop in U.S. revenue, which was hurt by blockbuster cholesterol drug Lipitor losing patent protection....
Source : usnews-com
07:31 : Pfizer posts lower profit, lowers outlook - LONDON (MarketWatch) -- Pfizer Inc. on Tuesday reported a fourth-quarter profit of $1.44 billion, or 19 cents a share, down from $2.89 billion, or 36 cents a share, a year earlier. Sales dipped to $16.75 billion from $17.35 billion a year ...
Source : marketwatch-com

Pfizer 1/30/2012

18:26 : Leaner Pfizer Expects Clean Bill of Health - Since CEO Ian Read took over a little more than a year ago, Pfizer has shed billions of dollars in corporate flab. It may get a surprisingly clean bill of health at its annual checkup Tuesday morning.
Source : wsj-com
15:15 : Pfizer options active ahead of earnings - PFE - Pfizer Inc. – Signs of bearish sentiment on the drug maker cropped up in Pfizer options on Monday, one day prior to the Company’s fourth-quarter earnings release ahead of the opening bell on Tuesday Morning|Tuesday ...
Source : fxstreet-com
15:14 : Pfizer to Seek Approval for Menopause Drug - Pfizer is preparing to seek U.S. regulatory approval to sell a new menopause drug that could pose an alternative to the company's older hormone-replacement therapies.
Source : wsj-com

Pfizer 1/27/2012

14:45 : FDA clears Pfizer drug for advanced kidney cancer - WASHINGTON (AP) -- Patients with hard-to-treat kidney cancer that has spread to other parts of the body gained a new drug option Friday, after federal regulators approved a twice-a-day pill from Pfizer for the disease....
Source : usnews-com

Pfizer 1/17/2012

19:04 : Summary Box: Pfizer, Medivation end drug's testing - STRIKE OUT: An experimental Alzheimer's drug doctors hoped would be the first to stop or even reverse the course of the mind-robbing disease failed in a third study, dashing hopes....
Source : usnews-com
07:42 : Pfizer, Medivation end drug development deal - NEW YORK (AP) -- Drug developers Pfizer and Medivation are ending the development of a potential Alzheimer's disease treatment after the drug yielded disappointing results in a late-stage clinical study....
Source : usnews-com
07:40 : Medivation (MDVN) and Pfizer (PFE) announce that their jointly-developed ... - Medivation (MDVN) and Pfizer (PFE) announce that their jointly-developed Dimebon treatment of Alzheimer's failed to achieve statistically significant results for endpoints in a Phase III trial. Due to the development, the ...
Source : seekingalpha-com
07:38 : Medivation, Pfizer end efforts on Alzheimer's drug - TEL AVIV (MarketWatch) -- Medivation Inc., the San Francisco biopharma firm, and Pfizer Inc., the New York health-care major, said Tuesday that dimebon, a drug they evaluated to treat Alzheimer's disease, didn't produce ...
Source : marketwatch-com

Pfizer 1/13/2012

05:33 : Nestle declines comment on Pfizer unit bid report - ZURICH (Reuters) - Nestle , the world's biggest food group, declined to comment on a report it had placed a bid to buy Pfizer Inc's baby formula business.
Source : reuters-com

Pfizer 1/12/2012

17:36 : Nestle (NSRGY.PK) and Danone (DANOY.PK) have made initial bids for Pfizer' - Nestle (NSRGY.PK) and Danone (DANOY.PK) have made initial bids for Pfizer's (PFE) baby-formula division, reports Bloomberg. However, sources claim Pfizer may still opt to spin off the business rather than sell it. It was claimed in July ...
Source : seekingalpha-com

Pfizer 1/10/2012

12:24 : Pfizer CEO focused on research revamp, partnering - SAN FRANCISCO (AP) -- Pfizer Inc.'s new CEO says he doesn't plan another huge deal like the $68 billion purchase of fellow drugmaker Wyeth two years ago....
Source : usnews-com

Pfizer 1/3/2012

10:31 : The FDA fast tracks a pneumonia vaccine from Pfizer ([[PFE]] +1.4%) for ... - The FDA fast tracks a pneumonia vaccine from Pfizer (PFE +1.4%) for use by adults aged 50 and older, drastically extending the reach for the drug beyond just use in children. Prevnar already stands as one of Pfizer's fastest-growing drugs ...
Source : seekingalpha-com

Pfizer 12/28/2011

17:30 : McDonald's, IBM, Pfizer On Track To Finish As Year's Best Dow Performers - While stocks wait for signs of a Santa rally this week, the biggest winners in the Dow Jones Industrial Average this year are ending the year up 20% o...

Pfizer 12/16/2011

08:30 : Pfizer reports positive Phase III drug trial - NEW YORK (MarketWatch) -- Pfizer Inc. said Friday a Phase III study of its Lyrica drug capsules for restless-leg syndrome met each of its three co-primary endpoints. The New York-based pharmaceutical company said it will continue to analyze ...
Source : marketwatch-com

Pfizer 12/15/2011

05:57 : Phylogica and Pfizer Complete First Stage of Peptide Vaccine Collaboration - PERTH, AUSTRALIA--(Marketwire - Dec 15, 2011) - Phylogica Ltd (ASX: PYC) (XETRA: PH7), a public Australian peptide drug discovery company, announced today the successful completion of the first stage of its collaboration with Pfizer to discover ...
Source : marketwire-com

Pfizer 12/12/2011

16:02 : Pfizer Boosts Dividend by 10%; Announces Stock Repurchases - Shares of Pfizer (NSYE: PFE) were trading Monday after the news down 1.17 percent, or 23 cents, to $20.32 at 3 p.m. Eastern Time. The stock was among the most actively traded on the NYSE. But the market as a whole was trading down on concerns ...
Source : ibtimes-com
actualidad Pfizer -
Logo Pfizer


Pharmaceuticals

Medical Supplies

Medical Equipment

Health Care Providers

Biotechnology

Copyright © 2009 Finaperf.com - Exchange rate - Investir - Stock Exchange - Börse - Finanças - Bolsa - Tous droits réservés
Site édité par Yanga.net - Contacts